Plexxikon Revenue and Competitors
Estimated Revenue & Valuation
- Plexxikon's estimated annual revenue is currently $3.4M per year.
- Plexxikon's estimated revenue per employee is $155,000
Employee Data
- Plexxikon has 22 Employees.
- Plexxikon grew their employee count by -4% last year.
Plexxikon's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Biologist | Reveal Email/Phone |
2 | SVP, Research | Reveal Email/Phone |
3 | Director, Nonclinical Development | Reveal Email/Phone |
4 | Senior Director, Intellectual Property | Reveal Email/Phone |
5 | Director, Dmpk | Reveal Email/Phone |
6 | Consulting Chief Medical Officer | Reveal Email/Phone |
7 | Manager, Clinical Drug Supply | Reveal Email/Phone |
8 | Information Technology Manager | Reveal Email/Phone |
9 | Senior Quality Assurance Specialist | Reveal Email/Phone |
10 | Scientist I, Computational Chemistry | Reveal Email/Phone |
Plexxikon Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Plexxikon?
Plexxikon, which was founded in December 2000, employs a novel approach to discovery in the post-genome era. The company uses innovative structure-based screening, with a focus on families of proteins sharing common folds, or domains, to discover and develop novel chemical scaffolds and small molecule leads for pharmaceutically relevant targets. The company plans to develop these leads independently and through corporate partnerships. Plexxikon completed an $8.2 million Series A Preferred Stock round of venture financing on May 11, 2001. Participants in the round included Alta Partners, CW Ventures, Advanced Technology Ventures (ATV), and Kumho Group.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Plexxikon News
Pigmented Villonodular Synovitis Drug Market Size 2022-2030| Key Players Bristol-myers Squibb Co, F. Hoffmann-la Roche Ltd, Novartis Ag, Plexxikon Inc.
Novartis AG; Plexxikon Inc. The study addresses the following product categories: Cabiralizumab; Emactuzumab; Mcs-110; Nilotinib; Others. The study...
In January, Daiichi Sankyo announced plans to close its Plexxikon R&D operations in South San Francisco, shuttering the small-molecule...
“Because they can offer the right product, they can take away unnecessary costs,” Kocher said. “And in healthcare, that’s what we really need to do.” Personalized medicine will help doctors determine what to treat, how to treat and how much to treat. That knowledge, Kocher said, will mean fewer ...
Other Companies in Berkeley
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.7M | 22 | -8% | N/A |
#2 | $3.4M | 22 | -24% | N/A |
#3 | $2.2M | 22 | 5% | N/A |
#4 | $3.9M | 22 | 16% | N/A |
#5 | $3.4M | 22 | 5% | N/A |